Cargando…

Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift

Among the major challenges in the development of biopharmaceuticals are structural heterogeneity and aggregation. The development of a successful therapeutic monoclonal antibody (mAb) requires both a highly active and also stable molecule. Whilst a range of experimental (biophysical) approaches exis...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, Michael J., Woolley, Rachel E., Kwok, Anthony, Parsons, Stuart, Jones, Hannah B. L., Gulácsy, Christina E., Phaal, Polly, Kassaar, Omar, Dawkins, Kieran, Rodriguez, Elizabeth, Marques, Andreia, Bowsher, Leo, Wells, Stephen A., Watts, Andrew, vandenElsen, Jean M. H., Turner, Alison, O'Hara, John, Pudney, Christopher R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527260/
https://www.ncbi.nlm.nih.gov/pubmed/32869839
http://dx.doi.org/10.1042/BCJ20200580
_version_ 1783589018754088960
author Knight, Michael J.
Woolley, Rachel E.
Kwok, Anthony
Parsons, Stuart
Jones, Hannah B. L.
Gulácsy, Christina E.
Phaal, Polly
Kassaar, Omar
Dawkins, Kieran
Rodriguez, Elizabeth
Marques, Andreia
Bowsher, Leo
Wells, Stephen A.
Watts, Andrew
vandenElsen, Jean M. H.
Turner, Alison
O'Hara, John
Pudney, Christopher R.
author_facet Knight, Michael J.
Woolley, Rachel E.
Kwok, Anthony
Parsons, Stuart
Jones, Hannah B. L.
Gulácsy, Christina E.
Phaal, Polly
Kassaar, Omar
Dawkins, Kieran
Rodriguez, Elizabeth
Marques, Andreia
Bowsher, Leo
Wells, Stephen A.
Watts, Andrew
vandenElsen, Jean M. H.
Turner, Alison
O'Hara, John
Pudney, Christopher R.
author_sort Knight, Michael J.
collection PubMed
description Among the major challenges in the development of biopharmaceuticals are structural heterogeneity and aggregation. The development of a successful therapeutic monoclonal antibody (mAb) requires both a highly active and also stable molecule. Whilst a range of experimental (biophysical) approaches exist to track changes in stability of proteins, routine prediction of stability remains challenging. The fluorescence red edge excitation shift (REES) phenomenon is sensitive to a range of changes in protein structure. Based on recent work, we have found that quantifying the REES effect is extremely sensitive to changes in protein conformational state and dynamics. Given the extreme sensitivity, potentially this tool could provide a ‘fingerprint’ of the structure and stability of a protein. Such a tool would be useful in the discovery and development of biopharamceuticals and so we have explored our hypothesis with a panel of therapeutic mAbs. We demonstrate that the quantified REES data show remarkable sensitivity, being able to discern between structurally identical antibodies and showing sensitivity to unfolding and aggregation. The approach works across a broad concentration range (µg–mg/ml) and is highly consistent. We show that the approach can be applied alongside traditional characterisation testing within the context of a forced degradation study (FDS). Most importantly, we demonstrate the approach is able to predict the stability of mAbs both in the short (hours), medium (days) and long-term (months). The quantified REES data will find immediate use in the biopharmaceutical industry in quality assurance, formulation and development. The approach benefits from low technical complexity, is rapid and uses instrumentation which exists in most biochemistry laboratories without modification.
format Online
Article
Text
id pubmed-7527260
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75272602020-10-06 Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift Knight, Michael J. Woolley, Rachel E. Kwok, Anthony Parsons, Stuart Jones, Hannah B. L. Gulácsy, Christina E. Phaal, Polly Kassaar, Omar Dawkins, Kieran Rodriguez, Elizabeth Marques, Andreia Bowsher, Leo Wells, Stephen A. Watts, Andrew vandenElsen, Jean M. H. Turner, Alison O'Hara, John Pudney, Christopher R. Biochem J Biophysics Among the major challenges in the development of biopharmaceuticals are structural heterogeneity and aggregation. The development of a successful therapeutic monoclonal antibody (mAb) requires both a highly active and also stable molecule. Whilst a range of experimental (biophysical) approaches exist to track changes in stability of proteins, routine prediction of stability remains challenging. The fluorescence red edge excitation shift (REES) phenomenon is sensitive to a range of changes in protein structure. Based on recent work, we have found that quantifying the REES effect is extremely sensitive to changes in protein conformational state and dynamics. Given the extreme sensitivity, potentially this tool could provide a ‘fingerprint’ of the structure and stability of a protein. Such a tool would be useful in the discovery and development of biopharamceuticals and so we have explored our hypothesis with a panel of therapeutic mAbs. We demonstrate that the quantified REES data show remarkable sensitivity, being able to discern between structurally identical antibodies and showing sensitivity to unfolding and aggregation. The approach works across a broad concentration range (µg–mg/ml) and is highly consistent. We show that the approach can be applied alongside traditional characterisation testing within the context of a forced degradation study (FDS). Most importantly, we demonstrate the approach is able to predict the stability of mAbs both in the short (hours), medium (days) and long-term (months). The quantified REES data will find immediate use in the biopharmaceutical industry in quality assurance, formulation and development. The approach benefits from low technical complexity, is rapid and uses instrumentation which exists in most biochemistry laboratories without modification. Portland Press Ltd. 2020-09-30 2020-09-28 /pmc/articles/PMC7527260/ /pubmed/32869839 http://dx.doi.org/10.1042/BCJ20200580 Text en © 2020 The Author(s) https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) (https://creativecommons.org/licenses/by/4.0/) . Open access for this article was enabled by the participation of University of Bath in an all-inclusive Read & Publish pilot with Portland Press and the Biochemical Society under a transformative agreement with JISC.
spellingShingle Biophysics
Knight, Michael J.
Woolley, Rachel E.
Kwok, Anthony
Parsons, Stuart
Jones, Hannah B. L.
Gulácsy, Christina E.
Phaal, Polly
Kassaar, Omar
Dawkins, Kieran
Rodriguez, Elizabeth
Marques, Andreia
Bowsher, Leo
Wells, Stephen A.
Watts, Andrew
vandenElsen, Jean M. H.
Turner, Alison
O'Hara, John
Pudney, Christopher R.
Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift
title Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift
title_full Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift
title_fullStr Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift
title_full_unstemmed Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift
title_short Monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift
title_sort monoclonal antibody stability can be usefully monitored using the excitation-energy-dependent fluorescence edge-shift
topic Biophysics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527260/
https://www.ncbi.nlm.nih.gov/pubmed/32869839
http://dx.doi.org/10.1042/BCJ20200580
work_keys_str_mv AT knightmichaelj monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT woolleyrachele monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT kwokanthony monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT parsonsstuart monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT joneshannahbl monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT gulacsychristinae monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT phaalpolly monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT kassaaromar monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT dawkinskieran monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT rodriguezelizabeth monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT marquesandreia monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT bowsherleo monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT wellsstephena monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT wattsandrew monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT vandenelsenjeanmh monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT turneralison monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT oharajohn monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift
AT pudneychristopherr monoclonalantibodystabilitycanbeusefullymonitoredusingtheexcitationenergydependentfluorescenceedgeshift